Dechra Pharmaceuticals PLC | Cash Flow
Fiscal year is July-June. All values GBP Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
59,047.00
19,459.00
19,493.00
33,214.00
34,100.00
Depreciation, Depletion & Amortization
20,537.00
21,538.00
27,802.00
47,299.00
7,400.00
Other Funds
1,558.00
-
-
-
-
Funds from Operations
36,802.00
43,341.00
45,718.00
70,528.00
87,400.00
Changes in Working Capital
25,070.00
2,342.00
2,110.00
6,930.00
23,400.00
Net Operating Cash Flow
11,732.00
40,999.00
43,608.00
77,458.00
64,000.00
Capital Expenditures
7,373.00
3,759.00
7,505.00
10,745.00
12,600.00
Purchase/Sale of Investments
-
-
-
11,013.00
-
Net Investing Cash Flow
76,315.00
4,667.00
174,068.00
57,307.00
241,700.00
Cash Dividends Paid - Total
12,579.00
13,857.00
15,292.00
17,664.00
21,800.00
Issuance/Reduction of Debt, Net
81,470.00
1,337.00
92,909.00
18,971.00
-
Net Financing Cash Flow
92,148.00
14,819.00
125,314.00
1,591.00
193,800.00
Net Change in Cash
6,018.00
19,175.00
6,806.00
22,058.00
18,500.00
Free Cash Flow
6,805.00
38,918.00
40,806.00
73,237.00
59,100.00
Net Assets from Acquisitions
5,938.00
908.00
166,563.00
35,549.00
229,100.00
Other Sources
91,202.00
-
-
-
-
Change in Capital Stock
343.00
375.00
47,697.00
284.00
103,300.00
Exchange Rate Effect
1,917.00
2,338.00
1,660.00
316.00
2,400.00
Other Uses
1,576.00
-
-
-
-
About Dechra Pharmaceuticals
View Profile
